Results 121 to 130 of about 3,733 (177)

Tyrosine kinase inhibitors - balancing the haemostatic scales: a review of associated thrombosis and bleeding. [PDF]

open access: yesJ Thromb Thrombolysis
Butel-Simoes LE   +8 more
europepmc   +1 more source

Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterations. [PDF]

open access: yesESMO Open
Piha-Paul SA   +13 more
europepmc   +1 more source

Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2-mutated post-MPN AML.

open access: yesBlood
Wang Z   +23 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Early Erythroblastic Leukemia Presenting asDe NovoAcute Leukemia

Leukemia & Lymphoma, 1990
Early erythroblastic leukemia is a newly defined type of leukemia in which the blasts have the same characteristics as erythroid precursors at the level of CFU-E. The blasts are characterized by the presence of carbonic anhydrase I, CD 36 antigen, platelet peroxidase (PPO)-like activity, and ferritin-containing granules.
T, Koike, E, Takakuwa, A, Shibata
openaire   +2 more sources

Acute erythroblastic leukemia presenting as acute undifferentiated leukemia: A report of two cases with ultrastructural features

Leukemia Research, 1985
This report describes two elderly patients with acute leukemia in which blast cells were undifferentiated with conventional light microscopy (L.M.) and cytochemistry. Blast cells were identified as belonging to the erythroblastic line by their ultrastructural features: glycogen deposits, lipidic vacuoles, cytoplasmic ferritin molecules and ...
J, Reiffers   +6 more
openaire   +2 more sources

Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidine

International Journal of Hematology, 2022
This study examined the prognostic impact of erythroblast predominance (EP) in 61 patients with myelodysplastic syndromes (MDS) (n = 51) or acute myeloid leukemia (n = 10) treated with azacitidine. Median age was 78 years. EP, defined as > 40% erythroblasts and M/E 
Akihito Matsuoka   +3 more
openaire   +2 more sources

Derivative (1;7)(q10;p10) in a Patient with de novo Acute Erythroblastic Leukemia (AML-M6)

Cancer Genetics and Cytogenetics, 1999
A rare association of der(1;7)(q10;p10) with de novo acute erythroblastic leukemia (AML-M6) in a 63-year-old male is reported. While this unbalanced 1;7 translocation, der(1;7), has been reported often in therapy-related myelodysplastic syndrome (t-MDS) or therapy-related acute myeloid leukemia (t-AML), its associations with de novo AML-FAB-M6 have ...
N, Obara   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy